Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis-Reference-Cited by-同舟云学术

Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis

Published:1995-12-14 Issue:24 Volume:333 Page:1600-1608
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Roujeau Jean-Claude,Kelly Judith P.,Naldi Luigi,Rzany Berthold,Stern Robert S.,Anderson Theresa,Auquier Ariane,Bastuji-Garin Sylvie,Correia Osvaldo,Locati Francesco,Mockenhaupt Maja,Paoletti Catherine,Shapiro Samuel,Shear Neil,Schöpf Erwin,Kaufman David W.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJM199512143332404

Cited by 1171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ocular, aural, and oral manifestations of lupus;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Awareness, knowledge, attitude, and practice of adverse drug reaction reporting among health workers in primary health centres participating in seasonal malaria chemoprevention campaign in Nigeria in 2022: a cross-sectional survey;BMC Health Services Research;2024-08-20

3. Stevens–Johnson syndrome-toxic epidermal necrolysis overlap in a patient taking quetiapine and famotidine: a case report;Journal of Medical Case Reports;2024-07-28

4. Lamotrigine Emerging as a Driver of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An 8-Year Retrospective Study;Burns;2024-07

5. Comparison of incidence, causes and prognosis of adult and paediatric epidermal necrolysis: a French population-based study;British Journal of Dermatology;2024-06-08